Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: A Phase I Trial of ZIO-101 in Hematologic Cancers [Phase 1]
This document reports the completion status of a Phase I trial evaluating ZIO-101 in hematologic cancers sponsored by Alaunos Therapeutics.
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: EMMA-1 (Erbitux for Multiple Myeloma) [Phase 2]
EMMA-1, a Phase 2 trial of cetuximab (Erbitux) for multiple myeloma, has been terminated; no results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Long-Term Follow Up Study for AMD3100 Patients
Long-term follow-up data from a completed trial evaluating AMD3100 (plerixafor) in patients with multiple myeloma were reported by MD Anders…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma [Phase 1]
A Phase 1 safety study evaluating dasatinib in combination with bortezomib and dexamethasone for multiple myeloma was terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma [Phase 1]
Phase I study of perifosine in combination with lenalidomide and dexamethasone in multiple myeloma has completed, with safety and early effi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma [Phase 3]
Phase 3 trial evaluating zoledronate with or without thalidomide in early-stage multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma [Phase 1]
A Phase 1 open-label dose-escalation study evaluating the safety and tolerability of the anti-KIR antibody 1-7F9 in patients with multiple m…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating lenalidomide, doxorubicin (Adriamycin), and dexamethasone induction followed by stem cell transplant in newly diagn…
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions [Phase 1]
Phase 1 clinical trial update on HLA Class I haplotype-mismatched natural killer cell infusions for hematologic cancers, including lymphoma,…
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study [Phase 1, Phase 2]
This Phase 1/2 trial evaluated adding bortezomib to high-dose melphalan followed by autologous peripheral blood stem cell transplant in mult…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Retrospective Survey of Re-treatment With Bortezomib
A retrospective study evaluating outcomes of patients with multiple myeloma treated again with bortezomib.
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia [Phase 2]
Phase 2 clinical trial update on bone marrow transplantation for patients with multiple myeloma, chronic myeloid leukemia (chronic phase), o…
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD [Phase 2]
Phase 2 study evaluating Velcade (bortezomib) plus dexamethasone, with or without cyclophosphamide or lenalidomide, in multiple myeloma pati…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation [Phase 2]
Phase 2 trial of peripheral blood lymphocyte therapy using EBV-specific cytotoxic T cells to prevent EBV-related lymphoproliferative disorde…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]
Phase 3 trial evaluating melphalan followed by peripheral stem cell transplantation in patients with multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a phase 1/2 study evaluating peripheral stem cell transplantation in patients with brea…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 clinical trial update on bone marrow and peripheral stem cell transplantation for patients with hematologic cancers; the study statu…
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating tocladesine for recurrent or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial of a combination including arsenic trioxide, thalidomide, dexamethasone, and ascorbic acid for relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders [NA]
Clinical trial update for a study evaluating G-CSF–treated donor bone marrow transplant in hematologic disorders; the trial (NCT00253552) is…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Cellular Therapy With Cord Blood Cells [Phase 2]
Phase 2 trial evaluating cord blood cell–based cellular therapy in patients with multiple myeloma, leukemia, or lymphoma. Results were poste…
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. [Phase 3]
Phase 3 trial update comparing MPR (melphalan-prednisone-thalidomide) with MP (melphalan-prednisone) in newly diagnosed multiple myeloma pat…
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone [Phase 1, Phase 2]
A Phase 1/2 trial compares mobilisation of peripheral blood progenitor cells using VTP195183 plus G-CSF versus G-CSF alone in patients with …
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 study evaluating Velcade (bortezomib) in relapsed/refractory multiple myeloma with bone-formation outcomes; the trial was terminated…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant [Phase 1]
The study evaluated transfusing KIR-ligand mismatched haplo-identical natural killer (NK) cells before autologous stem cell transplantation …